DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 35 filers reported holding DIAMEDICA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,000 | – | 273 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,197,245 | $2,993,000 | 1.24% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 265,000 | $663,000 | 0.40% |
| COOPERMAN LEON G | 812,508 | $2,031,270 | 0.11% |
| Ikarian Capital, LLC | 221,252 | $553,000 | 0.07% |
| Shay Capital LLC | 10,000 | $25,000 | 0.00% |
| Sandy Cove Advisors, LLC | 1,200 | $3,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 20,603 | $52,000 | 0.00% |
| Newbridge Financial Services Group, Inc. | 1,269 | $3,000 | 0.00% |
| Patriot Financial Group Insurance Agency, LLC | 1,300 | $3,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 20 | $0 | 0.00% |